iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, provides a clinical update on its lead asset, roginolisib.
Asahi Kasei Pharma has taken another step in its transformation into a global specialty pharmaceuticals company through a new licensing agreement with Chiome Bioscience for its humanised anti-CX3CR1 antibody.
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the close of a Series B extension financing round with an investment from EQT Life Sciences.
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024.
ArisGlobal’s director of product management’s Agnes Cwienczek, reports on AI-boosted regulatory process automation and other top-level findings from a new Censuswide survey of senior life sciences regulatory professionals.
MGS and Technolution, share how they take sustainability into consideration in their product design process using a transformative set of six Eco-Design Principles to help Pharma, Diagnostic and MedTech innovators reduce their environmental footprint
Steriline ends 2024 by consolidating its presence in the ophthalmic sector, a market in which Annex 1 has required a significant improvement in technologies.
Ellipses Pharma has published the latest data from an ongoing Phase 1/2 clinical trial of EP0042, an orally available novel agent that targets the Aurora kinase axis, in patients with acute myeloid leukaemia (AML).
